Understand the source comparison
Healing Peptides: Delivery Method Comparison
Subcutaneous injection 80–95% 15–30 min 4–8 hours (sequence dependent) Requires reconstitution; injection site reaction risk Gold standard for most healing peptides. Bypasses first-pass metabolism entirely Intramuscular injection 85–95% 10–20 min 6–12 hours De
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Subcutaneous injection
- 80–95%
- 15–30 min
- 4–8 hours (sequence dependent)
- Requires reconstitution; injection site reaction risk
- Gold standard for most healing peptides. Bypasses first-pass metabolism entirely
- Intramuscular injection
- 85–95%
- 10–20 min
- 6–12 hours
- Deeper injection technique; higher pain score
- Preferred for oil-based formulations; faster peak plasma levels than SubQ
- Oral (unmodified)
- <2%
- N/A
- Gastric acid denatures peptide bonds; proteolytic enzymes fragment sequence
- Ineffective for unmodified sequences. Marketing often overstates viability
- Oral (enteric-coated or modified)
- 5–15%
- 45–90 min
- Variable
- Requires chemical modification (PEGylation, cyclization); expensive formulation
- Possible for smaller peptides (<1000 Da) with protective coating
- Topical (dermal)
- 1–5% systemic; 10–25% local
- 30–60 min
- 2–4 hours
- Limited to skin/connective tissue within 2–3mm depth; molecular weight <500 Da ideal
- Effective for localized skin repair; poor systemic absorption
- Intranasal
- 10–30%
- 5–15 min
- 2–6 hours
- Nasal mucosa irritation; variable absorption based on formulation viscosity
- Emerging route for neuropeptides crossing blood-brain barrier
- Subcutaneous administration remains the dominant delivery method for research-grade peptides because it provides reproducible pharmacokinetics. When we guide researchers through Sermorelin protocols, subcutaneous administration into abdominal adipose tissue consistently produces peak plasma levels within 20–30 minutes with <15% inter-subject variability. Intramuscular injection shows faster peaks but higher variability due to blood flow differences between muscle groups.